Lifileucel tumor-infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors.

ABSTRACT:

SUBMITTER: Kluger H 

PROVIDER: S-EPMC12531414 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature